• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Bioventus, Inc.

    Bioventus Reports Third Quarter Financial Results
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus Reports Second Quarter Financial Results
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus Reports First Quarter Financial Results
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus Names Robert Claypoole as President and Chief Executive Officer
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus to Present at the Cantor Global Healthcare Conference
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus to Report Second Quarter of Fiscal Year 2023 Financial Results on August 8, 2023
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus Completes Divestiture of its Wound Business
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus Reports First Quarter Financial Results
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus Reschedules Reporting of First Quarter Fiscal Year 2023 Financial Results to After Market Close on May 16, 2023
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus Reschedules Earnings Call to May 16, 2023; Files for Extension to File Form 10-Q for the Period Ended April 1, 2023
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus Announces Divestiture of its Wound Business
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus to Report First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus Announces CEO Leadership Change
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus Reports Fourth Quarter and Full-Year 2022 Financial Results
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Bioventus Reschedules Reporting of Fourth Quarter Fiscal Year 2022 Financial Results to March 31, 2023
    From Bioventus, Inc.
    Via GlobeNewswire
    Tickers BVS
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.